Quintiles' bankrollers eye another $1B in second offering

Quintiles ($Q) founder Dennis Gillings and a trio of private equity backers hauled in more than $400 million when the company first went public last year, and now they're looking to reap nearly $1 billion more in a secondary public offering. Along with Bain Capital, TPG Capital and 3i, Gillings and associates are offering another 15 million shares in a follow-on offering, giving underwriters the option of buying 2.25 million more. Based on Quintiles' average stock price on Feb. 20, the offering would top out at $939.4 million, the CRO said in a regulatory filing. The company won't see any proceeds from the sale, which will benefit only the shareholders. Filing

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.